MP 820 (Levetiracetam extended release 750 mg)

Pill imprint MP 820 has been identified as Levetiracetam extended release 750 mg.

Levetiracetam is used in the treatment of epilepsy; seizures; bipolar disorder; new daily persistent headache; neuralgia (and more), and belongs to the drug class pyrrolidine anticonvulsants. Risk cannot be ruled out during pregnancy. Levetiracetam 750 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for MP 820

Levetiracetam extended release
Imprint:
MP 820
Strength:
750 mg
Color:
Pink
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Pyrrolidine anticonvulsants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mutual Pharmaceutical Company, Inc.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)